Cylex cylex.net


Cylex is a global life science company that develops, manufactures and commercializes in vitro diagnostic products intended to illuminate immunity in the area of transplant medicine. ImmuKnow is a noninvasive biomarker of immune function that assesses cellular immune status by detecting cell-mediated immunity (CMI) in populations undergoing immunosuppressive therapy for organ transplant.

Cylex is a global life science company that develops, manufactures and commercializes in vitro diagnostic products intended to illuminate immunity in the area of transplant medicine. ImmuKnow is a noninvasive biomarker of immune function that assesse...Show all

Company (Assets Purchased)

Phone: 410-964-0236

Fax:

8980-1 Old Annapolis RD

Columbia, 21045
Maryland, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Cylex $33M Feb 6, 2013
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Cylex Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 23 investors

Competitors

Company Status Description Investors

Hx Diagnostics

Emeryville, California, United States
Alive / ActiveHx Diagnostics offers rapid diagnostics for seasonal and emerging infectious diseases.Login to see details

Pathwork Diagnostics

Redwood City, California, United States
AcquiredPathwork Diagnostics Inc. is a privately held company that develops and delivers innovative molecular diagnostics for oncology. Pathwork's Tissue of Origin Test identifies the source of cancers that are difficult to classify and increases oncologists' confidence in their treatment approaches. It is the only FDA-approved molecular diagnostic test for tissue of origin. Login to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Method for monitoring the immune response and predicting clinical outcomes in transplant recipients Apr 11, 2003 Jan 13, 2009 Patent